LBRX
LB PHARMACEUTICALS INCCompany Information
- Company Name
- LB PHARMACEUTICALS INC
- CIK
- CIK0001691082
- Category
- <br>Emerging growth company
- Ticker: Exchange
- LBRX: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- LBRX
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-09-12
- Last sale
- —
- Shares purchased (TTM)
- 4,333,333
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 29,889,430
- Shares outstanding
- 30,137,733
- Ownership
- 99.18%
Earnings Market Reaction
- Filing date
- 2026-08-11
- Price on filing date
- —
- 1-month reaction
- 8.85%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
| Cash And Cash Equivalents At Carrying Value | 283 | 321 | 250 | 270 | ||||||
Assets Current | ||||||||||
| Assets Current | 355 | 389 | 308 | 316 | ||||||
| Marketable Securities Current | 45 | 45 | 45 | 45 | ||||||
| Prepaid Expense And Other Assets Current | 28 | 23 | 13 | 2 | ||||||
| Operating Lease Right Of Use Asset | 3 | 2 | 2 | 2 | ||||||
| Property Plant And Equipment Net | 2 | 2 | 2 | 2 | ||||||
| Restricted Cash Noncurrent | 1 | 1 | 1 | 1 | ||||||
| Assets | 362 | 393 | 313 | 321 | ||||||
Liabilities And Stockholders Equity | ||||||||||
| Accounts Payable Current | 3 | 7 | 2 | 3 | ||||||
Liabilities Current | ||||||||||
| Accrued Liabilities Current | 19 | 3 | 5 | 3 | ||||||
| Liabilities Current | 24 | 11 | 7 | 7 | ||||||
| Operating Lease Liability Current | 1 | 1 | 1 | 1 | ||||||
| Derivative Liabilities Noncurrent | 1 | 1 | 1 | 1 | ||||||
| Operating Lease Liability Noncurrent | 4 | 3 | 3 | 3 | ||||||
| Liabilities | 29 | 15 | 12 | 11 | ||||||
Statement Of Stockholders Equity | ||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 532 | 527 | 431 | 428 | ||||||
| Retained Earnings Accumulated Deficit | -200 | -149 | -130 | -118 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 0 | 0 | 0 | -0 | ||||||
| Stockholders Equity | 332 | 379 | 301 | 310 | ||||||
| Liabilities And Stockholders Equity | 362 | 393 | 313 | 321 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 500 | 500 | 500 | 500 | ||||||
| Common Stock Shares Issued | 29 | 29 | 25 | 25 | ||||||
| Preferred Stock Par Or Stated Value Per Share | - | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | - | 10 | 10 | 10 | ||||||
| Shares Outstanding | 29 | 29 | 25 | 25 | ||||||
Select a line item above to chart it.
Recent filings
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialLB PHARMACEUTICALS INC (LBRX) — SEC Financial Statements & Analysis
LB PHARMACEUTICALS INC (LBRX) is a pharmaceutical preparations company, incorporated in DE. LB PHARMACEUTICALS INC trades on Nasdaq as: LBRX. LB PHARMACEUTICALS INC (LBRX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-11. Based on that filing, LB PHARMACEUTICALS INC carries a market cap of $978.12M, a P/E ratio of -10.20x, a P/B ratio of 2.94x, an enterprise value of $695.01M, and an EV/EBITDA multiple of -7.28x. On profitability, it posts a Return on Equity (ROE) of -28.84%, a Return on Assets (ROA) of -26.50%, and a Return on Invested Capital (ROIC) of -194.70%. Per share, it reports EPS of $-3.18, diluted EPS of $-3.18, free cash flow per share of $-3.20, and a dividend per share of $0.00. On the balance sheet, it maintains a current ratio of 15.08x, a quick ratio of 13.91x, working capital of $331.74M, a debt-to-equity ratio of 0.09x, a debt ratio of 0.08, free cash flow of $-96.57M (TTM), and net debt of $-283.11M. Figures sourced from SEC EDGAR.
- Market Cap
- $978.12M
- P/E TTM
- -10.20x
- EPS TTM
- $-3.18
- P/B TTM
- 2.94x
- ROE TTM
- -28.84%
- ROA TTM
- -26.50%
- Debt To Equity
- 0.09x
- Free Cash Flow TTM
- $-96.57M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is LB PHARMACEUTICALS INC in?
LB PHARMACEUTICALS INC (LBRX) operates in the Pharmaceutical Preparations industry.
What exchange does LBRX trade on?
LB PHARMACEUTICALS INC (LBRX) trades on the Nasdaq.
Where is LB PHARMACEUTICALS INC incorporated?
LB PHARMACEUTICALS INC is incorporated in DE.
When was LB PHARMACEUTICALS INC (LBRX)'s most recent SEC filing?
LB PHARMACEUTICALS INC (LBRX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-11.
What is LBRX's market cap?
LB PHARMACEUTICALS INC (LBRX) has a market capitalization of $978.12M as of 2026-06-30.
What is LBRX's EPS (earnings per share)?
LB PHARMACEUTICALS INC (LBRX)'s trailing twelve month EPS is $-3.18 as of 2026-06-30.
What is LBRX's ROE (return on equity)?
LB PHARMACEUTICALS INC (LBRX)'s trailing twelve month Return on Equity (ROE) is -28.84% as of 2026-06-30.
What is LBRX's ROA (return on assets)?
LB PHARMACEUTICALS INC (LBRX)'s trailing twelve month Return on Assets (ROA) is -26.50% as of 2026-06-30.
What is LBRX's ROIC (return on invested capital)?
LB PHARMACEUTICALS INC (LBRX)'s trailing twelve month Return on Invested Capital (ROIC) is -194.70% as of 2026-06-30.
What is LBRX's EV/EBITDA?
LB PHARMACEUTICALS INC (LBRX)'s trailing twelve month EV/EBITDA is -7.28x as of 2026-06-30.